Document is current
Any future updates will be listed below
-
Authors
Jerves-Donoso, David
Garrosa, Manuel
Garcia-Sierra, Juan Felipe
Santamaría, Gema
Seco-Calvo, Jesús
Roche, Enrique
López-Llorente, Álvaro
Fernández-Lázaro, Diego
-
Funding
Funding for this research was provided by:
Ministry of Science and Innovation of the Government of Spain (PID2022-141358OBI00, PID2022-141358OBI00)
- License Information
-
More Information
Article History
Received: 9 February 2025
Accepted: 4 August 2025
First Online: 12 August 2025
Declarations
:
: The authors declare no competing interests.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: This study was conducted in accordance with the Declaration of Helsinki, and it was approved by the Institutional Review Board (Ethics Committee) of the Ethics Committee for Drug Research in the Valladolid area (PI 19-1361) and date of approval was April 25, 2019. ClinicalTrials.gov, identifier (ID NCT06806124). The trial was registered on February 3, 2025.
: All participants signed informed consent before examination.
: The authors declare that no Generative AI was used in the creation of this manuscript.
